Analyses / CRM
Large-cap SaaS leader at fair valuation; +3.8% today amid analyst divergence on AI monetization trajectory.
A free account reveals CRM's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
Dominant CRM platform with 77.7% gross margin and 18.9% operating leverage. Forward P/E 20.2x on 9.8% revenue growth + 12.2% 5-year CAGR signals disciplined execution. Dividend yield 0.93% + buybacks reflect capital return. AI monetization upside if Einstein adoption accelerates.
▼ Bear Case
Current ratio 0.76x and quick ratio 0.70x indicate tight liquidity for scale. P/S 3.6x near historical highs despite slowing growth (9.8% YoY). EV/EBITDA 23.9x suggests limited multiple expansion room. Analyst split on AI ROI signals uncertainty; execution risk on margin defense if growth doesn't accelerate.
Valuation
FAIRLY PRICED — score 62/100
P/E 18.8x and forward 20.2x are at historical mean for CRM; justified by 77.7% gross margin and 18.9% operating leverage, but not by 9.8% YoY revenue growth. P/S 3.6x and EV/EBITDA 23.9x suggest limited multiple upside absent AI acceleration.
Technical Levels
Support · $182.00 (Today's open / recent floor) · $170.00 (3-month moving average proxy) · $146.32 (52-week low)
Resistance · $195.00 (Day high / short-term ceiling) · $210.00 (3-month target) · $274.00 (52-week high)
RSI: Not provided
Financial Health
Score 72/100. Profitability and margin quality are strong; SaaS recurring revenue model ensures cash visibility. Liquidity ratios below 1.0 signal working-capital pressure (common for SaaS post-acquisition spree). Debt-to-equity not provided; recommend verifying balance sheet leverage. Beta 1.12 = moderate systematic risk.
Catalysts
| Q2–Q3 FY2025 Earnings & AI Monetization Guidance | Next 4–8 weeks | high |
| Einstein AI Usage & Customer Adoption Metrics | Quarterly updates / investor day | high |
| Federal Reserve Rate Path & Tech Multiple Repricing | Ongoing (latest: hold decision) | medium |
| Competitive AI Announcements (SAP, Oracle, Microsoft) | Continuous | medium |
Risk Flags
See CRM's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock CRM free →Recent News
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full CRM analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
CRM FAQ
Is CRM a buy right now?
Salesforce Inc's current read is a growth setup with 68 confidence over a 3-6 months horizon. Valuation: FAIRLY PRICED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is CRM overvalued?
FAIRLY PRICED (valuation score 62/100). P/E 18.8x and forward 20.2x are at historical mean for CRM; justified by 77.7% gross margin and 18.9% operating leverage, but not by 9.8% YoY revenue growth. P/S 3.6x and EV/EBITDA 23.9x suggest limited multiple upside absent AI acceleration.
What are the risks of buying CRM?
Current ratio 0.76x and quick ratio 0.70x indicate tight liquidity for scale. P/S 3.6x near historical highs despite slowing growth (9.8% YoY). EV/EBITDA 23.9x suggests limited multiple expansion room. Analyst split on AI ROI signals uncertainty; execution risk on margin defense if growth doesn't accelerate.